Medtronic (MDT) Liabilities and Shareholders Equity (2014 - 2026)

Medtronic has reported Liabilities and Shareholders Equity for 13 years, with the latest figure at $93.0 billion in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 1.47% year-over-year to $93.0 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $366.8 billion (up 1.49% YoY) and the FY2026 annual result came in at $93.0 billion, up 1.47% from the prior year.
• Liabilities and Shareholders Equity improved to $93.0 billion in Q2 2026 per MDT's latest filing, from $91.5 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $94.1 billion in Q1 2023 and troughed at $89.7 billion in Q3 2024.
• A 5-year average of $91.2 billion and a median of $91.0 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity fell 5.62% in 2022, then rose 2.54% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $93.2 billion in 2022, then fell by 3.38% to $90.1 billion in 2023, then decreased by 0.05% to $90.0 billion in 2024, then grew by 1.45% to $91.3 billion in 2025, then grew by 1.84% to $93.0 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $93.0 billion, $91.5 billion, and $91.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.